British Journal of Cancer - Table of Contents alert Volume 114 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 114, Issue 5 (485-604) Published online 1 March 2016 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Minireview Top Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve Michael I Koukourakis, Achilleas G Mitrakas and Alexandra Giatromanolaki Br J Cancer 2016 114: 485-496; advance online publication, February 18, 2016; 10.1038/bjc.2016.19 Abstract | Full Text Clinical Studies Top Do no harm: no psychological harm from colorectal cancer screening Benedicte Kirkøen, Paula Berstad, Edoardo Botteri, Tone Lise Åvitsland, Alvilde Maria Ossum, Thomas de Lange, Geir Hoff and Tomm Bernklev Br J Cancer 2016 114: 497-504; advance online publication, February 11, 2016; 10.1038/bjc.2016.14 Abstract | Full Text Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial Niall C Tebbutt, Timothy J Price, Danielle A Ferraro, Nicole Wong, Anne-Sophie Veillard, Merryn Hall, Katrin M Sjoquist, Nick Pavlakis, Andrew Strickland, Suresh C Varma, Prasad Cooray, Rosemary Young, Craig Underhill, Jennifer A Shannon, Vinod Ganju and Val Gebski on behalf of the Australasian Gastro-Intestinal Trials Group (AGITG) Br J Cancer 2016 114: 505-509; advance online publication, February 11, 2016; 10.1038/bjc.2015.440 Abstract | Full Text Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma Gary Middleton, William Greenhalf, Eithne Costello, Victoria Shaw, Trevor Cox, Paula Ghaneh, Daniel H Palmer and John P Neoptolemos Br J Cancer 2016 114: 510-518; advance online publication, February 4, 2016; 10.1038/bjc.2015.468 Abstract | Full Text Translational Therapeutics Top Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma Elena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Bernard Klein and Jerome Moreaux Br J Cancer 2016 114: 519-523; advance online publication, February 11, 2016; 10.1038/bjc.2016.20 Abstract | Full Text Molecular Diagnostics Top A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma Steven C Kao, Michaela B Kirschner, Wendy A Cooper, Thang Tran, Sjaak Burgers, Casey Wright, Tiny Korse, Daan van den Broek, James Edelman, Michael Vallely, Brian McCaughan, Nick Pavlakis, Stephen Clarke, Mark P Molloy, Nico van Zandwijk and Glen Reid Br J Cancer 2016 114: 524-531; advance online publication, February 18, 2016; 10.1038/bjc.2015.470 Abstract | Full Text Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins Yanxia Jin, Jie Wang, Xiangdong Ye, Yanting Su, Guojun Yu, Qing Yang, Wei Liu, Wenhui Yu, Jie Cai, Xi Chen, Yi Liang, Yijie Chen, Barry Hon Cheung Wong, Xiangning Fu and Hui Sun Br J Cancer 2016 114: 532-544; advance online publication, February 23, 2016; 10.1038/bjc.2015.348 Abstract | Full Text Arpin downregulation in breast cancer is associated with poor prognosis Maria E Lomakina, François Lallemand, Sophie Vacher, Nicolas Molinie, Irene Dang, Wulfran Cacheux, Tamara A Chipysheva, Valeria D Ermilova, Leanne de Koning, Thierry Dubois, Ivan Bièche, Antonina Y Alexandrova and Alexis Gautreau Br J Cancer 2016 114: 545-553; advance online publication, February 11, 2016; 10.1038/bjc.2016.18 Abstract | Full Text Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas Kosuke Hiramatsu, Kiyoshi Yoshino, Satoshi Serada, Kosuke Yoshihara, Yumiko Hori, Minoru Fujimoto, Shinya Matsuzaki, Tomomi Egawa-Takata, Eiji Kobayashi, Yutaka Ueda, Eiichi Morii, Takayuki Enomoto, Tetsuji Naka and Tadashi Kimura Br J Cancer 2016 114: 554-561; advance online publication, February 18, 2016; 10.1038/bjc.2016.27 Abstract | Full Text Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment James H Park, Arfon G Powell, Campbell S D Roxburgh, Paul G Horgan, Donald C McMillan and Joanne Edwards Br J Cancer 2016 114: 562-570; advance online publication, February 9, 2016; 10.1038/bjc.2016.17 Abstract | Full Text Epidemiology Top Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case–control study Anton Pottegård, Zandra Nymand Ennis, Jesper Hallas, Boye L Jensen, Kirsten Madsen and Søren Friis Br J Cancer 2016 114: 571-575; advance online publication, February 11, 2016; 10.1038/bjc.2016.10 Abstract | Full Text HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data T J Palmer, M McFadden, K G J Pollock, K Kavanagh, K Cuschieri, M Cruickshank, S Nicoll and C Robertson Br J Cancer 2016 114: 576-581; advance online publication, January 22, 2016; 10.1038/bjc.2015.473 Abstract | Full Text HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study T J Palmer, M McFadden, K G J Pollock, K Kavanagh, K Cuschieri, M Cruickshank, S Cotton, S Nicoll and C Robertson Br J Cancer 2016 114: 582-589; advance online publication, February 4, 2016; 10.1038/bjc.2015.474 Abstract | Full Text Effect of organised mammography screening on stage-specific incidence in Norway: population study Mette L Lousdal, Ivar S Kristiansen, Bjørn Møller and Henrik Støvring Br J Cancer 2016 114: 590-596; advance online publication, February 2, 2016; 10.1038/bjc.2016.8 Abstract | Full Text Cancer fear and fatalism among ethnic minority women in the United Kingdom Charlotte Vrinten, Jane Wardle and Laura AV Marlow Br J Cancer 2016 114: 597-604; advance online publication, February 11, 2016; 10.1038/bjc.2016.15 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.